"
Team:Bielefeld-Germany/Human Practice/pupil academy
From 2013.igem.org
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
{{Team:Bielefeld-Germany/Header2}} | {{Team:Bielefeld-Germany/Header2}} | ||
{{Team:Bielefeld-Germany/css/header_cleanup.css}} | {{Team:Bielefeld-Germany/css/header_cleanup.css}} | ||
Revision as of 22:44, 18 September 2013
Mediators
Of great interest is the production of endogenous mediators. The overexpression of glyceroldehydrogenase in ''E. coli'' is a promising approach. Because many derivates of glyceroldehydrogenase are small, water-soluble redoxmolecules, they have the properties of a mediator. Futhermore, it will be tested, if there is a possibility of expressing the mediator phenazin. Phenazin is an endogenous mediator of ''Pseudomonas'' species.
